These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1541323

  • 1. Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients.
    Kampf D, Borner K, Pustelnik A.
    Eur J Clin Pharmacol; 1992; 42(1):95-9. PubMed ID: 1541323
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D, Borner K, Pustelnik A.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [Abstract] [Full Text] [Related]

  • 3. The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure.
    White LO, MacGowan AP, Mackay IG, Reeves DS.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():65-72. PubMed ID: 3182464
    [Abstract] [Full Text] [Related]

  • 4. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Passlick J, Wonner R, Keller E, Essers L, Grabensee B.
    Perit Dial Int; 1989 Sep; 9(4):267-72. PubMed ID: 2488379
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J, Kantele S, Kivikko M, Häkkinen S, Harjola VP, Koskinen P, Pentikäinen PJ.
    Clin Pharmacokinet; 2007 Sep; 46(3):235-46. PubMed ID: 17328582
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
    Kliem V, Bahlmann J, Hartmann M, Huber R, Lühmann R, Wurst W.
    Nephrol Dial Transplant; 1998 May; 13(5):1189-93. PubMed ID: 9623552
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of ofloxacin in severe chronic renal failure.
    Bandai H, Tsubakihara Y, Yamato E, Yokoyama K, Okada N, Nakanishi I, Iida N.
    Clin Ther; 1989 May; 11(2):210-8. PubMed ID: 2736567
    [Abstract] [Full Text] [Related]

  • 13. Influence of haemodialysis on the pharmacokinetics of ciprofloxacin.
    Samsom JP.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S23-5. PubMed ID: 3438149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Removal of clodronate by haemodialysis in end-stage renal disease patients.
    Beigel AE, Rienhoff E, Olbricht CJ.
    Nephrol Dial Transplant; 1995 Dec 11; 10(12):2266-8. PubMed ID: 8808223
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.